Brian MacDonald

2.9k total citations
59 papers, 2.3k citations indexed

About

Brian MacDonald is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Brian MacDonald has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Hematology. Recurrent topics in Brian MacDonald's work include Bone health and treatments (13 papers), Bone Metabolism and Diseases (10 papers) and Bone health and osteoporosis research (9 papers). Brian MacDonald is often cited by papers focused on Bone health and treatments (13 papers), Bone Metabolism and Diseases (10 papers) and Bone health and osteoporosis research (9 papers). Brian MacDonald collaborates with scholars based in United States, United Kingdom and Denmark. Brian MacDonald's co-authors include Maxine Gowen, R.G.G. Russell, G. David Roodman, Gregory R. Mundy, D. E. Hughes, Thomas J. Kuehl, R Hahn, K J Ibbotson, J.A. Gallagher and Bert van Rietbergen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Brian MacDonald

57 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Brian MacDonald 1.1k 878 546 256 251 59 2.3k
Anthony J. Janckila 1.3k 1.2× 991 1.1× 573 1.0× 226 0.9× 279 1.1× 81 2.5k
Leonard Rifas 1.7k 1.6× 941 1.1× 562 1.0× 334 1.3× 630 2.5× 49 3.5k
Rowena D. Devlin 830 0.8× 696 0.8× 251 0.5× 76 0.3× 174 0.7× 20 1.6k
Oliver Bock 732 0.7× 289 0.3× 351 0.6× 605 2.4× 221 0.9× 100 2.6k
Simon W. Fox 1.5k 1.4× 946 1.1× 613 1.1× 80 0.3× 285 1.1× 40 2.5k
S. C. Manolagas 1.3k 1.2× 837 1.0× 786 1.4× 98 0.4× 182 0.7× 14 2.2k
Anne E. Hughes 1.0k 0.9× 574 0.7× 154 0.3× 151 0.6× 371 1.5× 59 3.0k
Gordon J Strewler 1.6k 1.5× 1.7k 1.9× 507 0.9× 71 0.3× 204 0.8× 76 3.1k
Abhishek Chandra 786 0.7× 405 0.5× 386 0.7× 180 0.7× 271 1.1× 63 1.9k
Su‐Li Cheng 2.4k 2.2× 682 0.8× 351 0.6× 338 1.3× 635 2.5× 53 4.4k

Countries citing papers authored by Brian MacDonald

Since Specialization
Citations

This map shows the geographic impact of Brian MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian MacDonald more than expected).

Fields of papers citing papers by Brian MacDonald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian MacDonald. The network helps show where Brian MacDonald may publish in the future.

Co-authorship network of co-authors of Brian MacDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Brian MacDonald. A scholar is included among the top collaborators of Brian MacDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian MacDonald. Brian MacDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ducamp, Sarah, Min Wu, Juan Putra, et al.. (2025). The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria. Journal of Clinical Investigation. 135(18). 1 indexed citations
2.
3.
4.
Wu, Min, Yue Chen, Scott A. Reisman, et al.. (2024). Inhibition of Glycine Transporter 1 Reduces Phototoxicity in a Mouse Model of Erythropoietic Protoporphyria (EPP). Blood. 144(Supplement 1). 2460–2460. 2 indexed citations
5.
Casu, Carla, Hal Drakesmith, Robert E. Fleming, et al.. (2019). Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major. Haematologica. 105(7). 1835–1844. 39 indexed citations
6.
Casu, Carla, Paraskevi Rea Oikonomidou, Huiyong Chen, et al.. (2016). Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera. Blood. 128(2). 265–276. 115 indexed citations
7.
Newitt, David C., Ying Lü, Brian MacDonald, Sharmila Majumdar, & Laurent Pothuaud. (2004). In vivo application of 3D-line skeleton graph analysis (LSGA) technique with high-resolution magnetic resonance imaging of trabecular bone structure. Osteoporosis International. 15(5). 411–419. 17 indexed citations
8.
Rietbergen, Bert van, G.v. Ingersleben, C. H. Chesnut, et al.. (2002). In Vivo Assessment of Architecture and Micro-Finite Element Analysis Derived Indices of Mechanical Properties of Trabecular Bone in the Radius. Osteoporosis International. 13(1). 6–17. 130 indexed citations
9.
MacDonald, Brian & Maxine Gowen. (2001). Emerging therapies in osteoporosis. Best Practice & Research Clinical Rheumatology. 15(3). 483–496. 10 indexed citations
10.
MacDonald, Brian, et al.. (2000). The effect of idoxifene on structural and mechanical properties of bone assessed by non invasive techniques in postmenopausal women. Journal of Bone and Mineral Research. 15(6). 1241–43. 1 indexed citations
11.
Mahalingam, Sundarasamy, Brian MacDonald, Kenneth E. Ugen, et al.. (1997). In Vitro and In Vivo Tumor Growth Suppression by HIV-1 Vpr. DNA and Cell Biology. 16(2). 137–143. 36 indexed citations
12.
MacDonald, Brian & Maxine Gowen. (1993). The cell biology of bone. Baillière s Clinical Rheumatology. 7(3). 421–443. 11 indexed citations
13.
Hahn, R, Brian MacDonald, Elizabeth N. Morgan, et al.. (1992). Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 979–989. 18 indexed citations
14.
MacDonald, Brian & Maxine Gowen. (1992). CYTOKINES AND BONE. Lara D. Veeken. 31(3). 149–155. 62 indexed citations
15.
Hughes, D. E., Brian MacDonald, R.G.G. Russell, & Maxine Gowen. (1989). Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.. Journal of Clinical Investigation. 83(6). 1930–1935. 302 indexed citations
16.
Takahashi, Nobuhiro, Toshio Kukita, Brian MacDonald, et al.. (1989). Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures.. Journal of Clinical Investigation. 83(2). 543–550. 67 indexed citations
17.
Gowen, Maxine, Brian MacDonald, R. Graham, & R.G.G. Russell. (1988). Actions of recombinant human γ‐interferon and tumor necrosis factor α on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis & Rheumatism. 31(12). 1500–1507. 87 indexed citations
18.
Hahn, R & Brian MacDonald. (1987). Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 62–69. 1 indexed citations
19.
MacDonald, Brian, et al.. (1984). Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.. Journal of Pharmacology and Experimental Therapeutics. 230(3). 558–568. 6 indexed citations
20.
MacDonald, Brian, James A. Gallagher, I. Ahnfelt‐Rønne, et al.. (1984). Effects of bovine parathyroid hormone and 1,25‐dihydroxyvitamin D3 on the production of prostaglandins by cells derived from human bone. FEBS Letters. 169(1). 49–52. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. Janckila Breakdown of academic impact, for papers by Leonard Rifas Breakdown of academic impact, for papers by Rowena D. Devlin Breakdown of academic impact, for papers by Oliver Bock Breakdown of academic impact, for papers by Simon W. Fox Breakdown of academic impact, for papers by S. C. Manolagas Breakdown of academic impact, for papers by Anne E. Hughes Breakdown of academic impact, for papers by Gordon J Strewler Breakdown of academic impact, for papers by Abhishek Chandra Breakdown of academic impact, for papers by Su‐Li Cheng
Rankless by CCL
2026